{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-357463","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2021-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.527670+00:00","generated_at":"2026-06-28T00:59:55.085139+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Vera Therapeutics appoints Kimball Hall to board of directors","bullets":["Kimball Hall appointed to Board effective December 10, 2021 as Class I director.","Granted stock option for 19,850 shares vesting monthly over 3 years.","Annual cash retainer of $35,000, pro-rated for 2021.","Eligible for annual option grant of 9,925 shares starting 2022 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-357463","json":"https://secwatch.observer/filing/0001193125-21-357463.json","markdown":"https://secwatch.observer/filing/0001193125-21-357463.md","text":"https://secwatch.observer/filing/0001193125-21-357463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/0001193125-21-357463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/d274787d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:59:55.085139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5065e3e2e9","claim":"Kimball Hall was appointed as Director at Vera Therapeutics, Inc..","evidence_excerpt":"On December 10, 2021, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Kimball Hall to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/0001193125-21-357463-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}